Wes (Janice) Brown

Publications

• Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
  Arai, S., Sahaf, B., Narasimhan, B., Chen, G. L., Jones, C. D., & Miklos, D. B. (2012). Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence. BLOOD, 119(25), 6145-6154.
• Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity
  Mueller, A. Ms., Shashidhar, S., Kuepper, N. J., Kohrt, H. Ek., Florek, M., & Shizuru, J. A. (2012). Co-transplantation of pure blood stem cells with antigen-specific but not bulk T cells augments functional immunity. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(15), 5820-5825.
• Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation
  Johnston, L., Florek, M., Armstrong, R., McCune, J. S., Arai, S., & Negrin, R. (2012). Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation. BONE MARROW TRANSPLANTATION, 47(4), 581-588.
• Early CMV Viremia Is Associated with Impaired Viral Control following Nonmyeloablative Hematopoietic Cell Transplantation with a Total Lymphoid Irradiation and Antithymocyte Globulin Preparative Regimen Schaenman, J. M., Shashidhar, S., Rhee, C., Wong, J., Navato, S., & Brown, J. M. (2011). Early CMV Viremia Is Associated with Impaired Viral Control following Nonmyeloablative Hematopoietic Cell Transplantation with a Total Lymphoid Irradiation and Antithymocyte Globulin Preparative Regimen. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 17(5), 693-702.
  
• Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY Naik, S., Wong, R., Arai, S., Brown, J., Laport, G., & Johnston, L. (2011). Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY. BONE MARROW TRANSPLANTATION, 46(2), 192-199.
  
• Treatment of Acyclovir-Resistant Herpes Simplex Virus with Continuous Infusion of High-Dose Acyclovir in Hematopoietic Cell Transplant Patients Kim, J. H., Schaenman, J. M., Ho, D. Y., & Brown, J. My. (2011). Treatment of Acyclovir-Resistant Herpes Simplex Virus with Continuous Infusion of High-Dose Acyclovir in Hematopoietic Cell Transplant Patients. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 17(2), 259-264.
  
• Combined Effects of Interleukin-7 and Stem Cell Factor Administration on Lymphopoiesis after Murine Bone Marrow Transplantation Chung, B., Min, D., Joo, L. W., Krampf, M. R., Huang, J., & Weinberg, K. I. (2011). Combined Effects of Interleukin-7 and Stem Cell Factor Administration on Lymphopoiesis after Murine Bone Marrow Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 17(1), 48-60.
  
• A 39-Year-Old Woman With Lupus, Myositis, and a Recalcitrant Vasculopathy Sokolove, J., Copland, A., Shirvani, S., Brown, J., Posley, K., & Chung, L. (2010). A 39-Year-Old Woman With Lupus, Myositis, and a Recalcitrant Vasculopathy. ARTHRITIS CARE & RESEARCH, 62(9), 1351-1356.
  
• Utility of Influenza Vaccination for Oncology Patients Pollyea, D. A., Brown, J. My., & Horning, S. J. (2010). Utility of Influenza Vaccination for Oncology Patients. JOURNAL OF CLINICAL ONCOLOGY, 28(14), 2481-2490.
  
• Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation Vana, M. L., Formankova, D., Cha, S., Sharma, A., Potena, L., & Mocarski, E. S. (2008). Comparison of polymerase chain reaction of polymorphonuclear leukocytes and plasma identifies patients who control cytomegalovirus infection after hematopoietic cell transplantation. CLINICAL INFECTIOUS DISEASES, 47(4), 535-539.
  
• Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects Wloch, M. K., Smith, L. R., Boutsaboualoy, S., Reyes, L., Han, C., & Boeckh, M. (2008). Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects. JOURNAL OF INFECTIOUS DISEASES, 197(12), 1634-1642.
  
• The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation Nguyen, V. H., Shashidhar, S., Chang, D. S., Ho, L., Kambham, N., & Negrin, R. S. (2008). The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. BLOOD, 111(2), 945-953.
  
• Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination Noda, S., Aguirre, S. A., Bitmansour, A., Brown, J. M., Sparer, T. E., & Mocarski, E. S. (2006). Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. BLOOD, 107(1), 30-38.
  
• Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted Arber, C., Bitmansour, A., Shashidhar, S., Wang, S., Tseng, B., & Brown, J. My. (2005). Protection against lethal Aspergillus fumigatus infection in mice by allogeneic myeloid progenitors is not major histocompatibility complex restricted. JOURNAL OF INFECTIOUS DISEASES, 192(9), 1666-1671.
  
• Stepwise development of committed progenitors in the bone marrow that generate functional T cells in the absence of the thymus Garcia-Ojeda, M. E., Dejbakhsh-Jones, S., Chatterjea-Matthes, D., Mukhopadhyay, A., Bitmansour, A., & Strober, S. (2005). Stepwise development of committed progenitors in the bone marrow that generate functional T cells in the absence of the thymus. JOURNAL OF IMMUNOLOGY, 175(7), 4363-4373.
  
• Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation Dvorak, C. C., Steinbach, W. J., Brown, J. My., & Agarwal, R. (2005). Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation. BONE MARROW TRANSPLANTATION, 36(7), 621-629.
  
• Treatment of verruca vulgaris with topical cidofovir in an immunlocompromised patient: a case report and review of the literature Cha, S., Johnston, L., Natkunam, Y., & Brown, J. (2005). Treatment of verruca vulgaris with topical cidofovir in an immunlocompromised patient: a case report and review of the literature. TRANSPLANT INFECTIOUS DISEASE, 7(3-4), 158-161.
  
• Exogenous administration of immunomodulatory therapies in hematopoietic cell transplantation: an infectious diseases perspective Brown, J. My. (2005). Exogenous administration of immunomodulatory therapies in hematopoietic cell transplantation: an infectious diseases perspective. CURRENT OPINION IN INFECTIOUS DISEASES, 18(4), 352-358.
  
• The influence of the conditions of hematopoietic cell transplantation on infectious complications Brown, J. My. (2005). The influence of the conditions of hematopoietic cell transplantation on infectious complications. CURRENT OPINION IN INFECTIOUS DISEASES, 18(4), 346-351.
  
• Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia Bitmansour, A., Cao, T. M., Chao, S., Shashidhar, S., & Brown, J. My. (2005). Single infusion of myeloid progenitors reduces death from Aspergillus fumigatus following chemotherapy-induced neutropenia. BLOOD, 105(9), 3535-3537.
  
• Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease Johnston, L. J., Brown, J., Shizuru, J. A., Stockerl-Goldstein, K. E., Stuart, M. J., & Chao, N. J. (2005). Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 11(1), 47-55.
  
• Fungal infections in bone marrow transplant patients Brown, J. My. (2004). Fungal infections in bone marrow transplant patients. CURRENT OPINION IN INFECTIOUS DISEASES, 17(4), 347-352.
  
• Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation Arber, C., Bitmansour, A., Sparer, T. E., Higgins, J. P., Mocarski, E. S., & Brown, J. My. (2003). Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation. BLOOD, 102(2), 421-428.
  
• Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation Bitmansour, A., Burns, S. M., Traver, D., Akashi, K., Contag, C. H., & Brown, J. My. (2002). Myeloid progenitors protect against invasive aspergillosis and Pseudomonas aeruginosa infection following hematopoietic stem cell transplantation. BLOOD, 100(13), 4660-4667.
  
• Prophylactic administration of liposomal amphotericin B is superior to treatment in a murine model of invasive aspergillosis after hematopoietic cell transplantation Bitmansour, A., & Brown, J. My. (2002). Prophylactic administration of liposomal amphotericin B is superior to treatment in a murine model of invasive aspergillosis after hematopoietic cell transplantation. JOURNAL OF INFECTIOUS DISEASES, 186(1), 134-137.
  
• Immunity to infections following hematopoietic cell transplantation Brown, J. M., Weissman, I. L., & Shizuru, J. A. (2001). Immunity to infections following hematopoietic cell transplantation. CURRENT OPINION IN IMMUNOLOGY, 13(4), 451-457.
  
• Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome Mocarski, E. S., Prichard, M. N., TAN, C. S., & Brown, J. M. (1997). Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome. VIROLOGY, 239(1), 169-175.
  
• SELECTABLE INSERTION AND DELETION MUTAGENESIS OF THE HUMAN CYTOMEGALOVIRUS GENOME USING THE ESCHERICHIA-COLI GUANOSINE PHOSPHORIBOSYL TRANSFERASE (GPT) GENE Greaves, R. F., Brown, J. M., VIEIRA, J., & Mocarski, E. S. (1995). SELECTABLE INSERTION AND DELETION MUTAGENESIS OF THE HUMAN CYTOMEGALOVIRUS GENOME USING THE ESCHERICHIA-COLI GUANOSINE PHOSPHORIBOSYL TRANSFERASE (GPT) GENE. JOURNAL OF GENERAL VIROLOGY, 76, 2151-2160.
  
• DRAMATIC INTERSTRAIN DIFFERENCES IN THE REPLICATION OF HUMAN CYTOMEGALOVIRUS IN SCID-HU MICE Brown, J. M., Kaneshima, H., & Mocarski, E. S. (1995). DRAMATIC INTERSTRAIN DIFFERENCES IN THE REPLICATION OF HUMAN CYTOMEGALOVIRUS IN SCID-HU MICE. JOURNAL OF INFECTIOUS DISEASES, 171(6), 1599-1603.